Colruyt: FY24/25F set to be in line with recently revised guidance. Exor: In search of a €2bn deal. Flow Traders: Sell In May And Go Away. Kinepolis: Peer Cineplex May 2025 box office revenue up 63% YoY, at 81% of 2019 level. Staffing: Dutch Period 5 - May vols up, strong pricing, working days/comps might distort. Staffing: French staffing - strong April data, May outlook also better
We reiterate our BUY rating on Colruyt but reduce our target price from €48 to €45.5 following the profit warning management issued on Friday. Colruyt's share price has corrected by c.15% following this release, despite consensus needing only to cut estimates by c.5% at EBIT level, in our view. Furthermore, we believe that the competitive environment should improve for Colruyt, as: (1) we lap tough comps on competitors opening stores on Sundays; and (2) Colruyt's potential to also open on Sunday...
AB InBev: Cash is King. Adecco: 4Q24 result beats by 6%, stabilising trends in 4Q24, balance sheet relief. ASM International: 1H25 guidance slightly better but orders missed in 4Q24. Colruyt: Expects to open OKay stores on Sundays. Deceuninck: Soft FY24 results due to Turkey. DEME Group: Strong FCF. JDE Peet's: Mean green beans. Kinepolis: Peer AMC 4Q24 results. NEPI Rockcastle: Strong performance at all levels. Wolters Kluwer: FY24 results; in line, new CEO in 2026
Belgian food retail: Carrefour plans to open all its stores on Sundays. Coca-Cola Europacific Partners: On course for FTSE inclusion. CVC Capital Partners: Stronger for longer. Econocom: REBITA in line but EBIT, net profit and net debt miss materially. Euronext: Strong finish. KPN: New “Althio” tower company deal closed. Recticel: Recovery in the Belgian construction sector expected by 2027F. Umicore: In-line 2024 and 2025 EBITDA guide, dividend cut and rebased. Wereldhave: €167m...
We reiterate our BUY rating on Colruyt but reduce our target price from €52 to €48 due to a c.2% lower EBIT forecast over the medium term and an increase in 10-year treasury yields. We remain convinced Colruyt's current discount to peers is unwarranted, given its healthy balance sheet and EBIT growth over the medium term. At our €48 target price, Colruyt would trade at 11.2x EV/EBIT FY25/26F, a 5% discount to its 12m fwd EV/EBIT average over-the-cycle and a c.10% discount to European Food Retail...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.